CRP and hydrops fetalis: A study in 2006 by Sola et al. [33] demonstrated that in patients with non-ischemic HF, left ventricular EF is increased with decreases in pro-inflammatory mediators interleukin (IL-6), tumor-necrosis factor-alpha receptor type II (TNF-aRII), and C-reactive protein (CRP) while on a daily dose of 20 mg atorvastatin.